Results 1 to 3 of 3

Thread: Research Leaders Discuss Issues in Moving Research to Human Trials

  1. #1
    Senior Member chastev8's Avatar
    Join Date
    Mar 2002
    valdosta ga usa

    Research Leaders Discuss Issues in Moving Research to Human Trials

    On February 3rd and 4th, 2003, Miami Project Scientific Director W. Dalton Dietrich, Ph.D., joined leaders of other major North American spinal cord injury (SCI) research groups in Bethesda, Maryland at a workshop entitled "Translating Promising Strategies for Spinal Cord Injury Therapy." The National Institute of Neurological Disorders and Stroke (NINDS) has initiated new funding programs to actively accelerate translational research. Thus it is especially timely for SCI research groups to openly discuss and coordinate their efforts to translate promising pre-clinical research to human clinical trials. The workshop, sponsored by NINDS, was designed to promote the exchange of information about the scope and aims of each group's programs and enlist their help in identifying, targeting and accelerating research areas ready for translation.

    Naomi Kleitman, Ph.D., NINDS Program Director and workshop organizer said, "As the lead federal funding agency for SCI research, the NINDS is ideally suited to initiate and lead discussions among major SCI research groups to focus on the translation of basic research to clinical studies." She developed the workshop based on input from individual researchers as well as the International Campaign for Cures of SCI Paralysis, a group of voluntary agencies that fund SCI research in the United States, Canada, the United Kingdom and Australia. The Christopher Reeve Paralysis Foundation (CRPF) also provided support for the workshop.

    In addition to the leaders from various university-based research programs, representatives from the NIH, Food and Drug Administration, Veterans Administration and the CRPF and International Spinal Research Trust participated. "The breadth of representation and the direct interaction between private, public, funding, regulatory, and research agencies was truly exceptional," continued Kleitman.

    Strategies being pursued in multidisciplinary translational research were discussed candidly, as areas of both agreement and controversy emerged. The meeting was considered very valuable for all involved, and a working group involving basic scientists and clinical researchers was developed to provide follow-up on trial development for the larger SCI research community.

  2. #2
    Senior Member mk99's Avatar
    Join Date
    Jul 2001
    toronto, canada

    I certainly hope MP is feeling some serious pressure. They need to know how our community is not just going to sit there quietly anymore.

    Director of Scientific Research at Miami Project is Dalton Dietrich. He can be reached at:

    please take a moment to write to him and let him know how important it is for you to move therapies to human ASAP. We expect nothing less. If Australia, China, Portugal, Taiwan & Russia can do human trials, why can't we?

  3. #3
    Senior Member Leo's Avatar
    Join Date
    Jul 2001
    Yankton, South Dakota
    Thanks Mike, did it!

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts